Intravesical Administration of Radiolabelled Tumour-associated Monoclonal Antibody in Bladder Cancer

Open Access
Publisher Website
Google Scholar
Abstract
Considerable progress has been made over the past decade in the use of tumour-associated monoclonal antibodies (mAbs) as carriers of cytotoxic agents in the management of several malignancies. In the present study we investigated the tumour localization and biodistribution of the mAb HMFG1 to bladder cancer following intravesical administration. HMFG1, which has been raised against the polymorphic epithelial mucin (PEM), was labelled with 125